Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on X:
“Big win for bladder cancer care!
FDA approves neoadjuvant and adjuvant durvalumab (NIAGARA trial) in MIBC!
Chemo and immunotherapy before surgery. Immunotherapy after.
PFS and OS both improved.
Proud to be one of investigator of this milestone!”
More posts featuring Yüksel Ürün.
